Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. THIRD AMENDED AND RESTATED...License Agreement • August 9th, 2023 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
